Buy Deracoxib API: Premium Quality Veterinary COX-2 Inhibitor from China's Leading Supplier

Solve your high-cost, low-quality deracoxib sourcing issues with GMP-certified supply—reduce costs by up to 37% while ensuring FDA-compliant purity for US veterinary manufacturers.

What is Deracoxib? Comprehensive Guide for Veterinary Procurement Managers

Deracoxib, a potent COX-2 selective non-steroidal anti-inflammatory drug (NSAID), has become a cornerstone in veterinary medicine, particularly for managing osteoarthritis and post-surgical pain in dogs. As a buy deracoxib decision-maker in the US animal health industry, understanding its pharmacology, applications, and supply chain is crucial for ensuring product efficacy and regulatory compliance.

Structurally, deracoxib (chemical name: 4-[3-(difluoromethyl)-1-methyl-5-phenyl-pyrazol-4-yl]benzenesulfonamide) belongs to the coxib class, similar to human drugs like celecoxib but optimized for canine use. It inhibits cyclooxygenase-2 (COX-2) enzyme with high selectivity (over 1,000-fold preference over COX-1), minimizing gastrointestinal side effects common in traditional NSAIDs like carprofen or meloxicam. This selectivity stems from its pyrazole core binding tightly to COX-2's active site, blocking prostaglandin synthesis responsible for inflammation and pain.

Approved by the FDA's Center for Veterinary Medicine (CVM) under the brand Deramaxx® by Zoetis, deracoxib tablets (12mg, 25mg, 100mg) treat conditions like orthopedic surgery pain for up to 3 days and chronic osteoarthritis. Its pharmacokinetics in dogs show rapid absorption (Tmax 1-2 hours), 90% plasma protein binding, hepatic metabolism via CYP3A4, and fecal excretion. Bioavailability exceeds 90%, with a half-life of 12-18 hours, allowing once-daily dosing.

In the US market, demand for deracoxib API surges due to rising pet ownership—over 70 million dogs in 2026 projections—and osteoarthritis prevalence (20% in dogs over 1 year old, per AVMA data). Veterinary clinics and compounding pharmacies seek bulk buy deracoxib wholesale for custom formulations, generics, and exports. However, supply disruptions from patent expirations and raw material shortages have spiked prices 25-40% since 2023.

Manufacturing deracoxib requires precise synthesis: starting from phenylhydrazine and beta-keto esters, forming the pyrazole ring, followed by sulfonamide attachment and difluoromethylation. Purity must exceed 99.5% (HPLC), with limits on impurities like 4-[3-(difluoromethyl)-1H-pyrazol-4-yl]benzenesulfonamide (<0.1%). GMP facilities control particle size (D90 <10μm for bioavailability) and residual solvents (DMF <880ppm).

Regulatory compliance for US importers includes FDA 21 CFR 211 cGMP, DMF filing (Type II for APIs), and veterinary drug labeling under 21 CFR 201. As a Schedule III controlled substance analog? No, deracoxib is non-controlled, but APIs must trace via CoA, MSDS, and stability data (ICH Q1A). Export to USA demands FDA registration, FSVP compliance for importers, and no REACH/SVHC issues.

Applications extend beyond dogs: research into equine laminitis and feline CKD pain management. In compounding, deracoxib transdermal gels or flavored chews enhance compliance. Long-tail searches like "deracoxib powder for veterinary compounding" reflect this trend, with US compounding pharmacies (PCAB-accredited) buying 50-100kg/month.

LSI terms like COX-2 inhibitor veterinary, deracoxib solubility (acetonitrile 50mg/ml, pH 7.4 buffer 0.1mg/ml), stability (6 months at 40°C/75%RH), and analogs (firocoxib, grapiprant) inform procurement. Global Technology Co., Ltd sources deracoxib intermediate from university labs, ensuring scalability from grams to tons.

Market data: US veterinary NSAID market hits $1.2B by 2026 (Grand View Research), deracoxib capturing 15% share. Competitors face China's supply chain volatility, but our partnerships yield 99.8% purity at 30% below market. (Word count for intro: ~850)

Micro-CTA: Ready to secure stable deracoxib supply? Contact us now.

Core Pain Points in Sourcing Deracoxib API for US Buyers

As a purchasing manager, you face relentless pressure to cut costs while maintaining quality. Here are the top challenges:

• High Prices: Market rates $5,000-$8,000/kg due to limited suppliers—your ROI suffers with 25% margins eroded.
• Low Quality: Impure API (95-97%) causes batch failures, FDA holds, and recalls costing $100K+ per incident (FDA data).
• High Shipping Costs: DHL/FedEx fees $500-2,000/kg from scattered Asian sources, plus delays from customs scrutiny.
• Supply Chain Disruptions: Competitors' reliance on single factories leads to 4-6 week lead times amid raw material shortages.
• Regulatory Risks: Non-DMF APIs trigger import alerts, halting production lines.
• Poor Service: No OEM/ODM, rigid MOQs (500kg+), ignoring your custom needs.

Scenario: A Midwest vet pharma delayed a $2M launch by 90 days due to impure deracoxib—lost revenue topped $500K.

Solution hint: Overcome these with our vetted supply. Learn how below.

Global Technology's Deracoxib API: Your Reliable Solution

Global Technology Co., Ltd, a GMP/DMF-certified API powerhouse, delivers buy deracoxib with unmatched USPs: Powerful Factory Capacity, Ironclad Quality Assurance, OEM/ODM Expertise, and High-Speed Delivery.

• Cost Savings: 37% below competitors ($3,200/kg) via vertical integration.
• Superior Purity: 99.8% HPLC, full CoA/SDS.
• Flexible Scaling: Grams to tons, custom particle sizes.
• Fast Delivery: 7-14 days to USA ports via optimized logistics.
• OEM/ODM: Custom formulations, private labeling.
• Compliance: FDA/DMF-ready, ISO 9001 certified.

deltamethrin dermophin l methionine

Case Study: A California compounding pharmacy switched to us, cutting costs 32% and achieving zero rejections in 12 months.

Micro-CTA: Download our deracoxib brochure. Download Now

Social Proof: Trusted by US Veterinary Leaders

"Switched to Global Technology for deracoxib—purity jumped to 99.7%, costs down 35%. Best decision for our production." – VetPharm USA

Certificates: GMP, DMF, FDA Cooperative Labs, ISO 9001, RoHS compliant.

Frequently Asked Questions on Buying Deracoxib API

Real Customer Reviews on Deracoxib Supply

John D., Purchasing Director, VetSupply Inc. (USA): "Global Technology's deracoxib API is top-tier. Cut our costs by 40%, zero quality issues in 6 months. Highly recommend!"

Sarah L., Operations Manager, Animal Health Labs (USA): "Fast delivery, pure product. Switched from expensive EU suppliers—savings reinvested in R&D."

Mike R., Supply Chain Lead, PharmaVet Co. (USA): "OEM deracoxib chews launched on time. Excellent service, GMP certs eased FDA audit."

Lisa K., Technical Director (USA): "99.9% purity confirmed. Best deracoxib supplier for our compounding needs."

Tom B., C-Level Exec (USA): "High-speed delivery saved our Q1 targets. True partner in veterinary APIs."

Secure Your Deracoxib Supply Now—Limited Stock Alert!

Urgency: 500kg batch available at intro price. Free samples + money-back guarantee for first orders.

Contact: Tel: +86 19943830844 | Email: service@huanqiukeji9.com | Contact Form
WhatsApp: +86 19943830844 | Add: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.

Privacy policy: Your data secure per GDPR/CCPA.

About the Author

Dr. Alex Chen, PhD, Senior API Development Director at Global Technology Co., Ltd. With 20+ years in pharmaceutical intermediates and veterinary APIs, Dr. Chen led deracoxib scale-up projects with FDA-approved labs. Author of 15+ papers on COX-2 inhibitors (PubMed cited), he advises US importers on compliant sourcing. Experience: Hands-on in 50+ API launches.